N-(3-carboxypropanoyl)-N-hydroxyputrescine

Metabolite details

Identifier

HJMSTRBGVUJGAI-UHFFFAOYSA-N

InChI Key

HJMSTRBGVUJGAI-UHFFFAOYSA-N

IUPAC name

4-[(4-aminobutyl)(hydroxy)amino]-4-oxobutanoic acid

Preferred name

N-(3-carboxypropanoyl)-N-hydroxyputrescine

INN name

—

Synonym

N-hydroxy-N-succinylputrescine

ChEBI

CHEBI:50430

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• Control_vs_OXPA_Treatment
• Control_vs_OXPA_Treatment
• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• Male_19_days_vs_Male_1_day
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d